{"name":"Corteria Pharmaceuticals","slug":"corteria-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"Corteria Pharmaceuticals is a biotechnology company focused on the development of innovative therapies, with a current pipeline featuring COR-1167 in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9uUi1OaFJKTWlOWTF2eWc1UWhDeGJUVklyQW93b182eklBcHgtaGRaaWhZWmhCN3N3empuTFFaam5Ia2l4NjBZWUFodmFLVnR2VnZHOWpDRk1XLUNMdnNwTXhJdE40c1RtaEQyVHZDc0JNcEVZajE4VmdTVDQ?oc=5","date":"2025-10-02","type":"trial","source":"pharmaphorum","summary":"Q3 Clinical trials round-up: July to September 2025 - pharmaphorum","headline":"Q3 Clinical trials round-up: July to September 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1EX2VmNEtESGljbW9pZkkzT3c5XzVZV1F6ZXlwZ0QwWjFTZ2pXRWgtUV8wZldxbXhuOHB0WmhDVm5uQ2F6aXVxWUl3Y2hMSFA2T0VsdU5QRmZWT3lmRXpPYk5vdFd6WG8tQ2FqY2VB?oc=5","date":"2025-06-10","type":"pipeline","source":"Labiotech.eu","summary":"These 18 french biotech startups could shape tomorrow’s medicine - Labiotech.eu","headline":"These 18 french biotech startups could shape tomorrow’s medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPU1BpN1dPYXg3R1NFN3JLa2JLTTFYY1J0SVR3eXFFRzdCclBTX0EwU2Y0R3hZckNVYU9BNDZEN2ZUU04tVHV2SFU3ejJZT0JuYmZ6bTVlaUdaN3RWMmNQWnB1b1lYelZ4YUNmbHBjMEdGRkh0aHhmRUJWQnlibG91eHI0QmNEQTJvUDc2WU9rcHE1QVcxeFBKdFdCWmpNQTM5TEd4Y2Q2M3hueFE?oc=5","date":"2025-05-07","type":"pipeline","source":"Medscape Reference","summary":"New Options in Treatment of Obesity/Overweight - Medscape Reference","headline":"New Options in Treatment of Obesity/Overweight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1UZWREMFhKVnBlUExnTHdvUDRVdENIMGstZThOQmx6NmpIQWl5RUhMeXRrc3ZTTTE5LVFiVm01UzdWSTRtbVZaenJfeEt5bDk0UXFUeDFfWC1JOEphMjAzRmhWZTRvalI5R0FkbDJjMThoN0t6TUg0aUx3?oc=5","date":"2024-06-30","type":"pipeline","source":"The Pharma Letter","summary":"Corteria Pharmaceuticals | Biotechnology | The Pharmaletter - The Pharma Letter","headline":"Corteria Pharmaceuticals | Biotechnology | The Pharmaletter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNMGVmV1pYU0YyY2JPOUFsVGhjbXhYNmlFeDZNVmVfOUp2alFOWHVFX1JKdTBzR2dLRDZGY05MRFJZeWRyNUVNTnlrek56UWY2ZUVuQ25xc1d4ZHlLb3NBTHFFcHJWRWc2S1BKOGdkNUN2SDZaYUU1Y2x1bHJMN2Q3N1Z1dVlCZmZLaFdfemFlcHQtaTdDazEtSTE5RWZiaE9WaUl3Rmtja3Y3dw?oc=5","date":"2023-09-07","type":"pipeline","source":"BioWorld News","summary":"Corteria closes $70.7M series A to advance heart failure candidates - BioWorld News","headline":"Corteria closes $70.7M series A to advance heart failure candidates","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}